A complete application in a minute — tailored resume and cover letter, ready to send.
CellAction, part of Institut Curie, is seeking a scientist to develop, optimize, and adapt manufacturing processes for cell- and gene-based therapies, including viral and non-viral vectors and genome editing. You will develop analytical methods, monitor key process parameters, and ensure compliance with regulatory requirements for clinical-grade production.
This role offers a dynamic, collaborative environment with opportunities for career development and a competitive salary package as you
CellAction is part of Institut Curie’s commitment to building unique expertise in cell and gene therapy. It integrates multidisciplinary competencies in bioinformatics, target discovery and validation, molecular biology, genome editing, viral and non-viral vector design, cell engineering, and the development of in vitro and in vivo tumor models for cell and gene therapy applications. Furthermore, CellAction provides pre-GMP process development expertise, aiming to generate fully characterized, GMP-ready cell therapy products that can be manufactured in dedicated GMP facilities and subsequently evaluated in clinical settings.
In 2025, CellAction was permanently established at the Saint-Cloud site of Institut Curie.
At the Process Development group at CellAction, our activities focus on the development and optimization of manufacturing processes for cell- and gene-based therapies, ensuring translational feasibility and compliance with regulatory standards for clinical-grade production.